<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Kollee, L.A.</title>
    <link>http://repub.eur.nl/res/aut/11862/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Motor performance in five-year-old extracorporeal membrane oxygenation survivors: A population-based study (Article)</title>
      <link>http://repub.eur.nl/res/pub/16423/</link>
      <pubDate>2009-04-02T00:00:00Z</pubDate>
      <description>Introduction: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a cardio-pulmonary bypass technique to provide life support in acute reversible cardio-respiratory failure when conventional management is not successful. Most neonates receiving ECMO suffer from meconium aspiration syndrome (MAS), congenital diaphragmatic hernia (CDH), sepsis or persistent pulmonary hypertension (PPH). In five-year-old children who underwent VA-ECMO therapy as neonates, we assessed motor performance related to growth, intelligence and behaviour, and the association with the primary diagnosis. Methods: In a prospective population-based study (n = 224) 174 five-year-old survivors born between 1993 and 2000 and treated in the two designated ECMO centres in the Netherlands (Radboud University Medical Centre Nijmegen and Sophia Children's Hospital, Erasmus MC - University Medical Center Rotterdam) were invited to undergo follow-up assessment including a paediatric assessment, the movement assessment battery for children (MABC), the revised Amsterdam intelligence test (RAKIT) and the child behaviour checklist (CBCL). Results: Twenty-two percent of the children died before the age of five, 86% (n = 149) of the survivors were assessed. Normal development in all domains was found in 49% of children. Severe disabilities were present in 13%, and another 9% had impaired motor development combined with cognitive and/or behavioural problems. Chi-squared tests showed adverse outcome in MABC scores (P &lt; 0.001) compared with the reference population in children with CDH, sepsis and PPH, but not in children with MAS. Compared with the Dutch population height, body mass index (BMI) and weight for height were lower in the CDH group (P &lt; 0.001). RAKIT and CBCL scores did not differ from the reference population. Total MABC scores, socio-economic status, growth and CBCL scores were not related to each other, but negative motor outcome was related to lower intelligence quotient (IQ) scores (r = 0.48, P &lt; 0.001). Conclusions: The ECMO population is highly at risk for developmental problems, most prominently in the motor domain. Adverse outcome differs between the primary diagnosis groups. Objective evaluation of long-term developmental problems associated with this highly invasive technology is necessary to determine best evidence-based practice. The ideal follow-up programme requires an interdisciplinary team, the use of normal-referenced tests and an international consensus on timing and actual outcome measurements.</description>
    </item> <item>
      <title>The role of parents in end-of-life decisions in neonatology: physicians' views and practices (Article)</title>
      <link>http://repub.eur.nl/res/pub/8779/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: End-of-life decisions for newborn infants are usually made with
          the consent of parents as well as physicians, but may occasionally involve
          disagreement about which decision is in the best interest of the child.
          Our study was aimed at providing an empirical background for the ethical
          discussion on the parent's versus the physician's role in decision-making.
          METHODS: We conducted face-to-face interviews with a stratified sample of
          pediatricians. The response rate was 99%. The most recent decisions in
          newborn infants to hasten death or not prolong life and the most recent
          cases in which such decisions were not made because either the parents or
          the physician objected were comprehensively discussed. RESULTS: Decisions
          to hasten death or not prolong life were usually made after discussing it
          with parents and did not occur while parents were known to disagree.
          Situations in which an end-of-life decision was not made because parents
          did not consent predominantly involved infants with complications of
          prematurity (24%) or perinatal asphyxia (40%), whereas situations in which
          parents requested an end-of-life decision that was not acceded to by the
          pediatrician involved Down syndrome as the main diagnosis in 43% and as a
          concurrent diagnosis in 21%. Pediatricians afterwards often expressed
          feelings of discontent about situations in which there had been
          disagreement with parents. CONCLUSIONS: The opinion of parents about which
          medical decision is in the best interest of their child is for
          pediatricians only decisive in case it invokes the continuation of
          treatment. The principle of preserving life is abandoned only when the
          physician feels sufficiently sure that the parents agree that such a
          course of action is in the best interest of the child.</description>
    </item>
  </channel>
</rss>